A phase 3 randomized, historically-controlled clinical trial investigating the use of defibrotide in the treatment of severe veno occlusive disease Post-SCT: A novel approach to the validation of a promising new drug for the treatment of a life threatening disease Meeting Abstract
| Authors: | Richardson, P.; Keman, N.; Tomblyn, M.; Martin, P.; Arai, S.; Brochstein, J.; Guinan, E.; Steinbach, G.; Nemecek, E.; D'Agostino, R.; Revta, C.; Hannah, A.; Lacobelli, M.; Soiffer, R. |
| Abstract Title: | A phase 3 randomized, historically-controlled clinical trial investigating the use of defibrotide in the treatment of severe veno occlusive disease Post-SCT: A novel approach to the validation of a promising new drug for the treatment of a life threatening disease |
| Meeting Title: | 49th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 110 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2007 Dec 8-11 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2007-11-01 |
| Start Page: | 189A |
| Language: | English |
| ACCESSION: | WOS:000251100800615 |
| PROVIDER: | wos |
| PUBMED: | 18092369 |
| DOI: | 10.1182/blood.V110.11.614.614 |
| Notes: | --- - Meeting Abstract: 614 - 49th Annual Meeting of the American-Society-of-Hematology - DEC 08-11, 2007 - Atlanta, GA - Part 1 - "Source: Wos" |
